Company Overview and News

 
Closing Bell: Sensex sheds 306 pts, Nifty ends below 10,500 on weaker rupee

19h moneycontrol
Market Closing: Benchmark indices after yesterday's breather resumed selling pressure again, with the Sensex losing more than 300 points on weaker rupee and global weakness.

 
Market Live: Nifty extends losses, Sensex down 200 pts; HPCL, BPCL, IOC dip 4-9%

20h moneycontrol
Earnings: Archies has reported net profit of Rs 30.6 crore in the Q4FY18 against loss of Rs 1.6 crore in the same quarter last fiscal.

 
Market Live: Nifty extends losses, Sensex down 100 pts; Motherson dips, Bajaj Electricals gains

21h moneycontrol
Earnings Reaction: GVK Power share price rallied 10 percent after the company reported profit at Rs 23.1 crore in March quarter 2018 against loss of Rs 205.8 crore in March quarter 2017.

 
NSE issues show-cause notice to UB Holdings, 15 others for delisting of shares

22h thehindubusinessline
Leading stock exchange NSE has issued a show-cause notice to defaulter businessman Vijay Mallya-led UB (Holdings) for delisting of its shares as trading has been suspended for a long time due to regulatory non-compliance.

 
Market Live: Sensex, Nifty rangebound; rupee hits fresh 16-month low

22h moneycontrol
IMD on Monsoon: India Meteorological Department said it did not see possibility of El Nino this year.

 
NEPC India Limited - Public Notice - Compulsory Delisting

2018-05-22 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
NEPC India Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-24 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
NEPC India Limited - Financial Result Updates

2017-10-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
NEPC India Limited - Results

2017-10-09 nseindia

 
 
Eyes on IRB InvIT, CDSL, NTPC results

2017-07-28 thehindubusinessline
Saturday will see a host of companies announcing their April-June financial results. These include Balkrishna Industries, CDSL, Central Bank of India, Dena Bank, Gujarat Ambuja Exports, GHCL, IRB InvIT Fund, Kitex Garments, Mangalore Chemicals, NEPC India, NTPC, NEPC Textiles, Omaxe, Pfizer, Seshasayee Paper and Boards, Superhouse, Sharda Cropchem, Valecha Engineering (for Q4 and full year ended March 2017), and Vardhman Special Steels.

 
NEPC India Limited - Results

2017-07-07 feedproxy.google

 
NEPC India Limited - Results

2017-07-07 feedproxy.google

 

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...